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Idiopathic Chylothorax; is it a benign or malignant diagnosis?
Sandra Naffouj, MD; Jasmine Omar, MD
Henry Ford Health System / Wayne State University
Detroit, Michigan

Background
• Chylothorax is the presence of chyle in the pleural space
with a triglyceride (TG) level >110 mg/dl or evidence of
chylomicrons in the pleural fluid.
• The main etiologies for chylothorax are traumatic (thoracic
surgery) and non-traumatic (malignancy).

Case Presentation

Case Presentation
• Pleural biopsy was negative for malignancy. Serum LDH, AFP,
B-hCG, HIV, AFB, fungal, and anaerobic cultures were all
negative. Peripheral blood smear was negative for dysplasia and
blasts. Full body CT did not show any evidence of malignancy.

Images

• 29-year-old healthy male presenting with acute onset of
dyspnea and right-sided pleuritic chest pain.
• CT chest showed large right-sided pleural effusion.
Thoracentesis was performed, draining 2 liters of turbid
white pleural fluid; a chest tube was placed.

• Patient underwent video assisted thoracoscopy (VATs) and
TD ligation. Output downtrend, pleural effusion resolved,
and chest tube was removed. Diet was advanced to low-fat,
medium chain triglyceride (MCT) diet.
• No leak recurrence at 1-month follow-up.

• An evaluation of the most common causes of non-traumatic
chylothorax include:
 Malignancy (lymphomas, lung and mediastinal cancers)
 Infections (tuberculosis, fungal infections)
 Congenital disorders of the lymphatic system
• Conservative management includes:
 Nothing by mouth or a low-fat diet with MCTs
 TPN to replace protein and electrolytes, and deliver lipids
directly into the bloodstream, thereby bypassing the
lymphatic system and decreasing chyle flow.
 Octreotide is an adjunct to help reduce chyle absorption
from the intestines.
• Possible interventional modalities include:
 TD embolization
 TD ligation
 Pleurodesis

• Pleural fluid analysis: exudative effusion with lymphocytic
predominance and TG of 1,100 mg/dl. Cytology and
cultures negative for malignancy and infection.
• Patient was made NPO; TPN and IV Octreotide were
started. Lymphangiogram showed chyle leak from the
thoracic duct (TD) at the level of T7-T8. He underwent
embolization, however high-volume chyle leakage was
persistent.

Discussion

Figure 1 (A,B): Lymphatic scan demonstrating TD leak

• A combination of conservative and operative interventions was
performed in our case given high-output of chyle and absence
of a clear etiology.
• It is crucial to perform a comprehensive assessment in nontraumatic chylothorax to exclude occult underlying etiology.

Figure 2:
Lymphangiography
Abdomen/Pelvis
with embolization
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